1-1 of 1
Michael Fidrik
Close
Sort by
Journal Articles

Alemtuzumab in B-Cell Prolymphoytic Leukemia (B-PLL) and Richter’s Transformation.

Michael Fiegl, Andreas Falkner, Michael Fidrik, Gerhard Postner, Alois Lang, Niklas Zojar, Guenther Gastl, Richard Greil, for the Austrian Cooperation on MabCampath Use in CLL
Journal: Blood
Blood (2006) 108 (11): 4733.
https://doi.org/10.1182/blood.V108.11.4733.4733
Published: 2006